Exercise Training on Health and Medical Costs of Metabolic Syndrome Individuals. (EXEisMED)

November 3, 2021 updated by: University of Castilla-La Mancha

Effectiveness of Exercise Training on Health and Medical Costs of Metabolic Syndrome Factors in the Adult Population.

The purpose of this study is to determine if an exercise training intervention together with conventional medical treatment can decrease the annual healthcare cost in patients with metabolic syndrome.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

It is proposed a multicentral clinical trial with cluster randomization among research nodes located in towns of Castilla-La Mancha and Toledo neighborhoods (Spain). The aim is to compare the annual healthcare cost of patients receiving conventional medical treatment against patients receiving the same intervention plus exercise training for 16 weeks. Exercise training will be based on high-intensity interval training conducted on stationary bikes, and strength training using weight-bearing exercises. Each research node will be composed of the clinical center and the sports facilities available in the town/neighborhood. Research nodes will be randomized into two experimental interventions: i.) conventional medical treatment, and ii.) conventional medical treatment + exercise training. After verbal and written information about the study and related potential risks, all patients fulfilling inclusion criteria will be included after giving written informed consent. At baseline, and after 12 and 24 months, annual healthcare costs will be obtained from the volunteers' clinical records. In addition, at baseline, and after 4, 12, and 24 months, metabolic syndrome components prevalence, metabolic syndrome z-score, body composition, and cardiorespiratory fitness will be tested.

Study Type

Interventional

Enrollment (Anticipated)

207

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

28 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Fulfilling criteria for metabolic syndrome diagnosis.

Exclusion Criteria:

  • At baseline, engagement to an exercise training program for the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: conventional medical treatment
Volunteers will maintain habitual medical treatment.
participants will maintain habitual medical treatment prescribed by primary care and specialized physicians from the public health service.
Experimental: exercise training + conventional medical treatment
Volunteers will maintain habitual medical treatment and will participate in a 16-week exercise training based on high-intensity interval training (stationary bikes), and strength training (weight-bearing exercises).
participants will maintain habitual medical treatment prescribed by primary care and specialized physicians from the public health service.
as appear in arm description.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Annual healthcare cost
Time Frame: Baseline, month 12 and 24
From unified medical records, all clinical and paraclinical interventions including pharmacological treatment, diagnostic or therapeutic procedures and primary care and specialized medical consultations will be included
Baseline, month 12 and 24

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiorespiratory fitness
Time Frame: Baseline, month 4,12, and 24.
Estimation of vo2max from a graded exercise test plus a verification test
Baseline, month 4,12, and 24.
Body composition
Time Frame: Baseline, month 4,12, and 24.
Measurement of the mass of man body compartments (i.e., fat mass, fat free mass, and bone mass) by dual energy x-ray absorptiometry.
Baseline, month 4,12, and 24.
Blood lipids profile
Time Frame: Baseline, month 4,12, and 24.
Serum concentrations (in mg per dL) of triglycerides, total colesterol, high density lipoprotein after 8-hour fasting
Baseline, month 4,12, and 24.
Glycemia
Time Frame: Baseline, month 4,12, and 24.
Serum concentrations of glycemia (in mg per dL) after 8-hour fasting
Baseline, month 4,12, and 24.
Blood pressure
Time Frame: Baseline, month 4,12, and 24.
Systolic and diastolic values of blood pressure measures obtained from the brachial artery after 15 min of supine rest.
Baseline, month 4,12, and 24.
Central obesity
Time Frame: Baseline, month 4,12, and 24.
Measurement of waist circumference (cm) in a horizontal plane, midway between the inferior margin of the ribs and the superior border of the iliac crest.
Baseline, month 4,12, and 24.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compliance to Exercise volume prescription .
Time Frame: Month 4
From the exercise training sessions records (exercise time in minutes), measurement of volume prescription (Target time)
Month 4
compliance to Exercise intensity prescription.
Time Frame: Month 4
From the exercise training sessions records (heart rate in beats per minute), measurement of compliance to exercise intensity prescription (target HR).
Month 4
Daily physical activity
Time Frame: Month 4,12, and 24.
Measurement of daily steps using pedometers
Month 4,12, and 24.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2021

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

December 31, 2025

Study Registration Dates

First Submitted

September 27, 2021

First Submitted That Met QC Criteria

November 3, 2021

First Posted (Actual)

November 15, 2021

Study Record Updates

Last Update Posted (Actual)

November 15, 2021

Last Update Submitted That Met QC Criteria

November 3, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on conventional medical treatment

3
Subscribe